A detailed history of Strategic Blueprint, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Strategic Blueprint, LLC holds 411 shares of IDXX stock, worth $193,720. This represents 0.02% of its overall portfolio holdings.

Number of Shares
411
Previous 438 6.16%
Holding current value
$193,720
Previous $243,000 9.05%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$515.08 - $576.87 $13,907 - $15,575
-27 Reduced 6.16%
411 $221,000
Q4 2023

Jan 25, 2024

BUY
$391.37 - $557.56 $171,420 - $244,211
438 New
438 $243,000
Q2 2023

Oct 18, 2023

SELL
$450.7 - $503.61 $1,352 - $1,510
-3 Reduced 0.47%
638 $320,000
Q1 2023

Apr 28, 2023

BUY
$406.01 - $514.59 $13,804 - $17,496
34 Added 5.6%
641 $320,000
Q4 2022

Jan 26, 2023

BUY
$324.64 - $441.27 $197,056 - $267,850
607 New
607 $0
Q2 2022

Aug 12, 2022

BUY
$327.37 - $553.44 $327 - $553
1 Added 0.16%
619 $217,000
Q1 2022

Aug 12, 2022

SELL
$466.52 - $631.01 $3,265 - $4,417
-7 Reduced 1.12%
618 $338,000
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $2,346 - $2,665
-4 Reduced 0.64%
625 $411,000
Q3 2021

Nov 12, 2021

SELL
$621.9 - $705.76 $1,865 - $2,117
-3 Reduced 0.47%
629 $391,000
Q2 2021

Aug 12, 2021

BUY
$486.36 - $637.08 $7,295 - $9,556
15 Added 2.43%
632 $399,000
Q1 2021

May 10, 2021

SELL
$465.18 - $551.79 $5,116 - $6,069
-11 Reduced 1.75%
617 $302,000
Q4 2020

Jan 26, 2021

SELL
$383.85 - $499.87 $383 - $499
-1 Reduced 0.16%
628 $314,000
Q3 2020

Oct 27, 2020

BUY
$334.54 - $406.31 $210,425 - $255,568
629 New
629 $247,000
Q4 2019

Jan 10, 2020

SELL
$248.66 - $285.01 $147,952 - $169,580
-595 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$260.07 - $289.93 $154,741 - $172,508
595 New
595 $162,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $39.2B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.